Results of 2025 Annual Shareholder Meeting

3 August 2025 Results of 2025 Annual Shareholder Meeting At AFT Pharmaceuticals Limited’s (NZX: AFT / ASX: AFP) annual shareholder meeting held at the Milford Cruising Club, 24 Craig Road, Milford, Auckland, New Zealand today, shareholders were asked to vote on four resolutions, all of which were supported by the Board. As required by NZX Listing Rule 6.1, all voting was conducted by a poll. The resolutions passed by shareholders were: 1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2026 financial year. 2. That Hartley Atkinson be re-elected as a director of AFT Pharmaceuticals Limited. 3. That Allison Yorston be elected as a director of AFT Pharmaceuticals Limited. Detail of the total number of votes cast in person or by a proxy holder are: Resolution For Against Abstain 1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2025 financial year. 91,547,849 99.97% 26,328 0.03% 8,684 2. That Hartley Atkinson be re-elected as a director of AFT Pharmaceuticals Limited. 91,555,813 99.97% 23,395 0.03% 3,653 3. That Allison Yorston be elected as a director of AFT Pharmaceuticals Limited. 91,533,592 99.95% 42,364 0.05% 6,905 Authority for this announcement Name of person authorised to make this announcement Malcolm Tubby, Chief Financial Officer Contact person for this announcement Malcolm Tubby Contact phone number +64 9 488 0232 Contact email address Investor.relations@aftpharm.com Date of release through MAP 3 August 2025